Respiratory Tract Infections News and Research

RSS

Coronavirus could turn into a new pandemic

With news that the coronavirus called 2019-nCoV is capable of spreading from human to human, many are concerned about the possibility of a new pandemic, and that is not outside the realm of possibility, according to Jeff Hogan, a professor and infectious disease expert at the University of Georgia, who studied the SARS coronavirus extensively.

24 Jan 2020

Sepsis killing more people than earlier thought

According to a new study published in the latest issue of The Lancet, this week, more people across the globe are dying of sepsis than earlier believed. A team from the University of Pittsburgh and University of Washington schools of medicine led the research along with their colleagues from different disciplines.

16 Jan 2020

Study finds air pollution increases suicide risk and depression

Cutting air pollution could significantly reduce global rates of depression, a new study finds.

18 Dec 2019

Under-5's receiving an average 25 antibiotic prescriptions each year

Antibiotic resistance is one of the greatest threats to mankind says the World Health Organization (WHO). One of the greatest contributors to this menace is indiscriminate use of antibiotics.

15 Dec 2019

Vanderbilt doctors offer tips on when to seek ED treatment for flu-like symptoms

'Tis the season for colds, flu and upper respiratory illnesses say health care providers at Monroe Carell Jr. Children's Hospital at Vanderbilt.

11 Dec 2019

Strong microbiome in early life linked to fewer respiratory infections

Researchers have discovered that networking between bacterial within the body's microbiome may protect babies from respiratory infections.

3 Oct 2019

Infants with well-connected bacterial networks have fewer respiratory infections

Microscopic bacteria, which are present in all humans, cluster together and form communities in different parts of the body, such as the gut, lungs, nose and mouth.

1 Oct 2019

Probiotic use helps reduce health care cost and societal impact of flu-like RTIs

A study published on August 27 in Frontiers in Pharmacology found that general probiotic use in the U.S. could save the health care payer and the economy around $1.4 billion in medical bills and lost productivity due to acute respiratory tract infections.

28 Aug 2019

Promising vaccine may protect against the Klebsiella superbug

A powerful superbug, a hypervirulent form of the bacteria Klebsiella pneumoniae, is a very difficult to curb infection. It causes a variety of infections including rare but life-threatening liver, respiratory tract, bloodstream and other infections.

28 Aug 2019

Antibiotic use linked to increased odds of developing rheumatoid arthritis

A new study has provided evidence that antibiotic usage is associated with an increased risk of developing rheumatoid arthritis.

26 Aug 2019

Multifaceted intervention for acute respiratory infection improves antibiotic-prescribing

Antibiotic stewardship interventions for acute respiratory infection) is feasible and effective and can significantly reduce overuse in the emergency department and urgent care center settings.

11 Jul 2019

$FDA grants accelerated approval to new treatment for refractory multiple myeloma$

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

3 Jul 2019

Scientists develop new, rapid test to diagnose bacterial lower respiratory tract infections

Scientists at the Quadram Institute and the University of East Anglia have developed a new, rapid way of diagnosing bacterial lower respiratory tract infections in hours rather than days, that could improve patient care and slow the spread of antimicrobial resistance.

24 Jun 2019

Oral steroid use in patients with inflammatory diseases increases risk of infection

Oral steroid use in patients with the inflammatory diseases polymyalgia rheumatica and/or giant cell arteritis significantly increased the risk of infection, and the risk increased with higher doses, found a study in CMAJ.

24 Jun 2019

Growing up on farm with animals may half risk of asthma and allergies, suggests study

Earlier research has shown that growing up on a farm with animals may as much as half the risk of asthma and allergies.

18 Jun 2019

Coat of proteins makes viruses more infectious and facilitates plaque formation in Alzheimer's

New research from Stockholm University and Karolinska Institutet shows that viruses interact with proteins in the biological fluids of their host which results in a layer of proteins on the viral surface.

27 May 2019

Online intervention lowers mothers' intentions to visit primary care clinician for respiratory tract infection

Visits to the doctor for a respiratory tract infection can lead to unnecessary antibiotic prescribing, but an online intervention with real-time information on locally circulating viruses may reduce mothers' intentions to visit their primary care doctor.

15 May 2019

“Without Antibiotics, I Cannot Treat”: Examining Antibiotic Resistance Drivers in India

Mohit Nair discusses the issue of antibiotic resistance in India and the work that MSF is doing to improve awareness and reduce the misuse of antibiotics.

7 May 2019

Outpatient healthcare providers inappropriately prescribe antibiotics to 40% of patients

Outpatient healthcare providers inappropriately prescribed antibiotics to 40 percent of patients in a major Veterans Affairs healthcare system, a higher figure than in previous studies examining outpatient antibiotic use, according to a new study appearing in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology published by Elsevier.

17 Apr 2019

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.

29 Mar 2019